A subsequent study demonstrated that RBP4 can activate antigen-presenting cells through the MyD 88-MAPK-NFκB pathway, leading to inflammatory infiltration in adipose tissue and inducing systemic insulin resistance [110, 111]. Here, RBP4 is linked to Insulin resistance.